Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 119 results
Author Title [ Type(Desc)] Year
Filters: Author is Ma, Xiaojing  [Clear All Filters]
Journal Article
Liu J, Guan X, Ma X.  2005.  Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.. J Biol Chem. 280(26):24347-55.
Liu J, Ma X.  2006.  Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappaB, and PU.1.. J Biol Chem. 281(28):19188-95.
D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G.  1993.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.. J Exp Med. 178(3):1041-8.
Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G.  1996.  The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.. J Exp Med. 183(1):147-57.
Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M, Han J, Silverstein R, Selleri L, Ma X.  2007.  Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1.. Immunity. 27(6):952-64.
Sartori A, Ma X, Gri G, Showe L, Benjamin D, Trinchieri G.  1997.  Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.. Methods. 11(1):116-27.
Liu J, Cao S, Kim S, Chung EY, Homma Y, Guan X, Jimenez V, Ma X.  2005.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.. Curr Immunol Rev. 1(2):119-137.
Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G.  1995.  Interleukin-12 production by human polymorphonuclear leukocytes.. Eur J Immunol. 25(1):1-5.
Kim SJun, Gershov D, Ma X, Brot N, Elkon KB.  2002.  I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation.. J Exp Med. 196(5):655-65.
Xiang Z, Yang Y, Ma X, Ding W.  2003.  Microarray expression profiling: analysis and applications.. Curr Opin Drug Discov Devel. 6(3):384-95.
Aste-Amezaga M, Ma X, Sartori A, Trinchieri G.  1998.  Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.. J Immunol. 160(12):5936-44.
Werts C, le Bourhis L, Liu J, Magalhaes JG, Carneiro LA, Fritz JH, Stockinger S, Balloy V, Chignard M, Decker T et al..  2007.  Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.. Eur J Immunol. 37(9):2499-508.
Chen L, Xu G, Song X, Zhang L, Chen C, Xiang G, Wang S, Zhang Z, Wu F, Yang X et al..  2024.  A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.. Cancer Lett. 583:216635.
Kim H, Zhao Q, Zheng H, Li X, Zhang T, Ma X.  2015.  A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation.. Sci Rep. 5:12018.
Ma X, Gri G, Trinchieri G.  1996.  A novel ets-2-related nuclear factor is involved in transcriptional activation of the human interleukin-12 p40 gene promoter in response to interferon-gamma and LPS stimulation of monocytic cells.. Ann N Y Acad Sci. 795:357-60.
Zhang Y, Lv D, Kim H-J, Kurt RA, Bu W, Li Y, Ma X.  2013.  A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.. Cell Res. 23(3):394-408.
Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, Li L.  2006.  Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples.. Endocrinology. 147(1):44-50.
Ma X.  2020.  The omentum, a niche for premetastatic ovarian cancer.. J Exp Med. 217(4)
Kim SJung, Gershov D, Ma X, Brot N, Elkon KB.  2003.  Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses.. Ann N Y Acad Sci. 987:68-78.
Ma X, Riemann H, Gri G, Trinchieri G.  1998.  Positive and negative regulation of interleukin-12 gene expression.. Eur Cytokine Netw. 9(3 Suppl):54-64.
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.  1998.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.
Ma X, D'Andrea A, Kubin M, Aste-Amezaga M, Sartori A, Monteiro J, Showe L, Wysocka M, Trinchieri G.  1995.  Production of interleukin-12.. Res Immunol. 146(7-8):432-8.
Yan W, Ding A, Kim H-J, Zheng H, Wei F, Ma X.  2016.  Progranulin Controls Sepsis via C/EBPα-Regulated Il10 Transcription and Ubiquitin Ligase/Proteasome-Mediated Protein Degradation.. J Immunol. 197(8):3393-3405.
Voshtani R, Song M, Wang H, Li X, Zhang W, Tavallaie MS, Yan W, Sun J, Wei F, Ma X.  2019.  Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.. Cancer Lett. 465:24-35.
Ma X, Montaner LJ.  2000.  Proinflammatory response and IL-12 expression in HIV-1 infection.. J Leukoc Biol. 68(3):383-90.